Rezolute, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Common Stock Registered Direct Offering 2021 [Member]	Common Stock EDA with Oppco	Common Stock Lincoln Park Capital Fund, LLC Purchase Agreement [Member]	Common Stock Registered Direct Offering 2022	Common Stock 2021 Underwritten Public Offering	Common Stock	Additional Paid-in Capital Registered Direct Offering 2021 [Member]	Additional Paid-in Capital EDA with Oppco	Additional Paid-in Capital Lincoln Park Capital Fund, LLC Purchase Agreement [Member]	Additional Paid-in Capital Registered Direct Offering 2022 Class A pre-funded warrants	Additional Paid-in Capital Registered Direct Offering 2022	Additional Paid-in Capital 2021 Underwritten Public Offering Pre-Funded Warrants 2021 [Member]	Additional Paid-in Capital 2021 Underwritten Public Offering	Additional Paid-in Capital	Accumulated Deficit	Registered Direct Offering 2021 [Member]	EDA with Oppco	Lincoln Park Capital Fund, LLC Purchase Agreement [Member]	Registered Direct Offering 2022 Class A pre-funded warrants	Registered Direct Offering 2022	2021 Underwritten Public Offering Pre-Funded Warrants 2021 [Member]	2021 Underwritten Public Offering	Total
Balance at Jun. 30, 2020						$ 6								$ 154,595	$ (147,236)								$ 7,365
Balance (in shares) at Jun. 30, 2020						5,867,000
Issuance of Units for cash Fiscal 2021 Equity Financing						$ 2								40,998									41,000
Issuance of Units for cash Fiscal 2021 Equity Financing (in shares)						2,485,000
Advisory fees, Underwriting commissions and other offering costs														(3,550)									(3,550)
Share-based compensation														3,965									3,965
Reclassification of warrants and stock options from equity to derivative liability due to authorized share deficiency														(3,591)									(3,591)
Reclassification of derivative liabilities to equity upon cure of authorized share deficiency														1,796									1,796
Fair value of warrants issued														8									8
Issuance of common stock for consulting services														8									8
Net loss															(20,902)								(20,902)
Balance at Jun. 30, 2021						$ 8								194,229	(168,138)								26,099
Balance (in shares) at Jun. 30, 2021						8,352,000
Gross proceeds from issuance of common stock for cash	$ 1	$ 1		$ 18	$ 6		$ 4,999	$ 1,518	$ 1,172		$ 64,372		$ 39,950			$ 5,000	$ 1,519	$ 1,172		$ 64,390		$ 39,956
Gross proceeds from issuance of common stock for cash (in shares)	769,000	138,000	116,000	18,026,000	6,147,000											769,231	138,388
Advisory fees, Underwriting commissions and other offering costs														(4,596)									(4,596)
Share-based compensation														3,685									3,685
Reclassification of derivative liabilities to equity upon cure of authorized share deficiency														35,025									35,025
Commitment shares issued under LPC Purchase Agreement									$ 450									$ 450
Commitment shares issued under LPC Purchase Agreement (in shares)			34,000															33,799
Fair value of warrants issued										$ 7,048		$ 10,783							$ 7,048		$ 10,783
Net loss															(41,060)								(41,060)
Balance at Jun. 30, 2022						$ 34								$ 358,635	$ (209,198)								$ 149,471
Balance (in shares) at Jun. 30, 2022						33,582,000